@ARTICLE{
author={Popovic Marjan,Stanojevic Zeljka S,Tosic Jelena,Isakovic Aleksandra J,Paunovic Verica G,Petricevic Sasa M,Martinovic Tamara I,Ciric Darko N,Kravic-Stevovic Tamara K,Soskic Vukic V,Kostic-Rajacic Sladjana V,Shakib Kaveh,Bumbasirevic Vladimir Z,Trajkovic Vladimir S},
year={2015},
title={Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats},
journal={JOURNAL OF NEUROCHEMISTRY},
volume={135},
number={1},
pages={125-138},
document_type={Article},
} 

@ARTICLE{
author={Sencanski Milan V,Sukalovic Vladimir B,Shakib Kaveh,Soskic Vukic V,Dosen-Micovic Ljiljana I,Kostic-Rajacic Sladjana V},
year={2014},
title={Molecular Modeling of 5HT(2A) Receptor - Arylpiperazine Ligands Interactions},
journal={CHEMICAL BIOLOGY & DRUG DESIGN},
volume={83},
number={4},
pages={462-471},
document_type={Article},
} 

@ARTICLE{
author={Sukalovic Vladimir B,Ignjatovic Djurdjica S,Tovilovic Gordana I,Andric Deana B,Shakib Kaveh,Kostic-Rajacic Sladjana V,Soskic Vukic V},
year={2012},
title={Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D-2 and 5-hydroxytryptamine 5HT(1A) receptors},
journal={BIOORGANIC & MEDICINAL CHEMISTRY LETTERS},
volume={22},
number={12},
pages={3967-3972},
document_type={Article},
}